Transport of benzo[α]pyrene in the dually perfused human placenta perfusion model: Effect of albumin in the perfusion medium

Line Mathiesen, Erik Rytting, Tina Mose, Lisbeth E. Knudsen

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Transport of benzo[α]pyrene (BaP) across the placenta was examined because it is a ubiquitous and highly carcinogenic substance found in tobacco smoke, polluted air and certain foods. Foetal exposure to this substance is highly relevant but is difficult to estimate. The human placenta is unique compared to other species; since it is available without major ethical obstacles, we have used the human placenta perfusion model to study transport from mother to foetus. Placentas were donated after births at Rigshospitalet in Copenhagen from pregnant mothers who signed an informed consent. BaP is lipophilic and studies using cell culture medium in 6-hr placenta perfusions showed minimal transport through the placenta. To increase the solubility of BaP in perfusion medium and to increase physiological relevance, perfusions were also performed with albumin added to the perfusion medium [2 and 30 mg/ml bovine serum albumin (BSA) and 30 mg/ml human serum albumin (HSA)]. The addition of albumin resulted in increased transfer of BaP from maternal to foetal reservoirs. The transfer was even higher in the presence of an HSA formulation containing acetyltryptophanate and caprylate, resulting in a foetal-maternal concentration (FM) ratio of 0.71 ± 0.10 after 3 hr and 0.78 ± 0.11 after 6 hr, whereas the FM ratio in perfusions without albumin was only 0.05 ± 0.03 after 6 hr of perfusion. Less BaP accumulated in placental tissue in perfusions with added albumin. This shows that transplacental transport of the pro-carcinogenic substance BaP occurs, and emphasizes the importance of adding physiological concentrations of albumin when studying the transport of lipophilic substances.

Original languageEnglish (US)
Pages (from-to)181-187
Number of pages7
JournalBasic and Clinical Pharmacology and Toxicology
Volume105
Issue number3
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Placenta
Albumins
Perfusion
Mothers
Serum Albumin
Caprylates
Tobacco
Bovine Serum Albumin
Cell culture
Smoke
Culture Media
Solubility
pyrene
Tissue
Informed Consent
Air
Fetus
Cell Culture Techniques
Parturition
Food

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Transport of benzo[α]pyrene in the dually perfused human placenta perfusion model : Effect of albumin in the perfusion medium. / Mathiesen, Line; Rytting, Erik; Mose, Tina; Knudsen, Lisbeth E.

In: Basic and Clinical Pharmacology and Toxicology, Vol. 105, No. 3, 09.2009, p. 181-187.

Research output: Contribution to journalArticle

@article{255bd476b098441d8d17d67349a325c6,
title = "Transport of benzo[α]pyrene in the dually perfused human placenta perfusion model: Effect of albumin in the perfusion medium",
abstract = "Transport of benzo[α]pyrene (BaP) across the placenta was examined because it is a ubiquitous and highly carcinogenic substance found in tobacco smoke, polluted air and certain foods. Foetal exposure to this substance is highly relevant but is difficult to estimate. The human placenta is unique compared to other species; since it is available without major ethical obstacles, we have used the human placenta perfusion model to study transport from mother to foetus. Placentas were donated after births at Rigshospitalet in Copenhagen from pregnant mothers who signed an informed consent. BaP is lipophilic and studies using cell culture medium in 6-hr placenta perfusions showed minimal transport through the placenta. To increase the solubility of BaP in perfusion medium and to increase physiological relevance, perfusions were also performed with albumin added to the perfusion medium [2 and 30 mg/ml bovine serum albumin (BSA) and 30 mg/ml human serum albumin (HSA)]. The addition of albumin resulted in increased transfer of BaP from maternal to foetal reservoirs. The transfer was even higher in the presence of an HSA formulation containing acetyltryptophanate and caprylate, resulting in a foetal-maternal concentration (FM) ratio of 0.71 ± 0.10 after 3 hr and 0.78 ± 0.11 after 6 hr, whereas the FM ratio in perfusions without albumin was only 0.05 ± 0.03 after 6 hr of perfusion. Less BaP accumulated in placental tissue in perfusions with added albumin. This shows that transplacental transport of the pro-carcinogenic substance BaP occurs, and emphasizes the importance of adding physiological concentrations of albumin when studying the transport of lipophilic substances.",
author = "Line Mathiesen and Erik Rytting and Tina Mose and Knudsen, {Lisbeth E.}",
year = "2009",
month = "9",
doi = "10.1111/j.1742-7843.2009.00431.x",
language = "English (US)",
volume = "105",
pages = "181--187",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Transport of benzo[α]pyrene in the dually perfused human placenta perfusion model

T2 - Effect of albumin in the perfusion medium

AU - Mathiesen, Line

AU - Rytting, Erik

AU - Mose, Tina

AU - Knudsen, Lisbeth E.

PY - 2009/9

Y1 - 2009/9

N2 - Transport of benzo[α]pyrene (BaP) across the placenta was examined because it is a ubiquitous and highly carcinogenic substance found in tobacco smoke, polluted air and certain foods. Foetal exposure to this substance is highly relevant but is difficult to estimate. The human placenta is unique compared to other species; since it is available without major ethical obstacles, we have used the human placenta perfusion model to study transport from mother to foetus. Placentas were donated after births at Rigshospitalet in Copenhagen from pregnant mothers who signed an informed consent. BaP is lipophilic and studies using cell culture medium in 6-hr placenta perfusions showed minimal transport through the placenta. To increase the solubility of BaP in perfusion medium and to increase physiological relevance, perfusions were also performed with albumin added to the perfusion medium [2 and 30 mg/ml bovine serum albumin (BSA) and 30 mg/ml human serum albumin (HSA)]. The addition of albumin resulted in increased transfer of BaP from maternal to foetal reservoirs. The transfer was even higher in the presence of an HSA formulation containing acetyltryptophanate and caprylate, resulting in a foetal-maternal concentration (FM) ratio of 0.71 ± 0.10 after 3 hr and 0.78 ± 0.11 after 6 hr, whereas the FM ratio in perfusions without albumin was only 0.05 ± 0.03 after 6 hr of perfusion. Less BaP accumulated in placental tissue in perfusions with added albumin. This shows that transplacental transport of the pro-carcinogenic substance BaP occurs, and emphasizes the importance of adding physiological concentrations of albumin when studying the transport of lipophilic substances.

AB - Transport of benzo[α]pyrene (BaP) across the placenta was examined because it is a ubiquitous and highly carcinogenic substance found in tobacco smoke, polluted air and certain foods. Foetal exposure to this substance is highly relevant but is difficult to estimate. The human placenta is unique compared to other species; since it is available without major ethical obstacles, we have used the human placenta perfusion model to study transport from mother to foetus. Placentas were donated after births at Rigshospitalet in Copenhagen from pregnant mothers who signed an informed consent. BaP is lipophilic and studies using cell culture medium in 6-hr placenta perfusions showed minimal transport through the placenta. To increase the solubility of BaP in perfusion medium and to increase physiological relevance, perfusions were also performed with albumin added to the perfusion medium [2 and 30 mg/ml bovine serum albumin (BSA) and 30 mg/ml human serum albumin (HSA)]. The addition of albumin resulted in increased transfer of BaP from maternal to foetal reservoirs. The transfer was even higher in the presence of an HSA formulation containing acetyltryptophanate and caprylate, resulting in a foetal-maternal concentration (FM) ratio of 0.71 ± 0.10 after 3 hr and 0.78 ± 0.11 after 6 hr, whereas the FM ratio in perfusions without albumin was only 0.05 ± 0.03 after 6 hr of perfusion. Less BaP accumulated in placental tissue in perfusions with added albumin. This shows that transplacental transport of the pro-carcinogenic substance BaP occurs, and emphasizes the importance of adding physiological concentrations of albumin when studying the transport of lipophilic substances.

UR - http://www.scopus.com/inward/record.url?scp=68849089587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849089587&partnerID=8YFLogxK

U2 - 10.1111/j.1742-7843.2009.00431.x

DO - 10.1111/j.1742-7843.2009.00431.x

M3 - Article

C2 - 19508462

AN - SCOPUS:68849089587

VL - 105

SP - 181

EP - 187

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 3

ER -